Biomarker Research

SJR Rank #612H-index: 69SJR: 3.303Best quartile: Q1Open AccessAPC: US$3,890Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.851.72.553.4

Subject Categories

  • Biochemistry (medical)Q1
  • Clinical BiochemistryQ1
  • Molecular MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchAcute Myeloid Leukemia ResearchCancer-related molecular mechanisms researchRNA modifications and cancerImmune cells in cancerMicroRNA in disease regulationLymphoma Diagnosis and TreatmentImmune Cell Function and InteractionCancer Genomics and Diagnostics

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202504080120160

Detailed Information

ISSN

2050-7771

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

10.78

References per Document

103.41

Coverage

2013-2026

Scope

Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. The study of biomarkers has evolved rapidly in the advance of personalized medicine and individual health. The identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era. With a quick turnaround time from submission to publication and online feedback from readers, Biomarker Research strives to provide fast dissemination of novel findings and new knowledge.

Metrics from SCImago Journal Rank 2025. View on SCImago